JFL Capital Management is a biotechnology-focused hedge fund based in Austin, Texas.

• Diligence: Independently developed investment theses through novel primary research, clinical data analysis, medical research conferences, and key opinion leader relationships.• Valuation: Built comprehensive financial statements and DCF valuations based on epidemiology data and competitive market analysis.•Routinely wrote statistical data analysis algorithms to analyze published clinical data for investment research.• Novel Research: Analyzed TCGA genome data and GEO gene expression data to support highly differentiated investment thesis in targeted cancer therapeutic company.

Identify/invent/implement computational biology methods for drug discovery and development. • Clinical and Preclinical Data Analysis: Developed computational method to understand/predict drug resistance in Ph2b infectious disease clinical trials. Built computational pipeline to analyze patient gut pharmacology in metabolic clinical trial. Performed phylogenetic analysis to characterize off-target toxicity risk from preclinical animal models• Strategic Development: Developed cloud computing strategy for R&D and led pilot project in collaboration with Amazon Web Services.• Organizational Leadership: Initiated and Chaired standards working group to formalize genomic analysis standards across R&D.